Daniela Moye Holz

Daniela Moye Holz

Research Leader

She/Her

Daniela Moye Holz is a research leader at RAND Europe. Working primarily on the Health and Care team, she is a public health expert with a background in pharmaceutical chemistry, global health, foresight studies and health policies. She has worked in several sectors, including the private pharmaceutical industry, academia, the public sector, and the non-profit sector. She has carried out health policy research for the WHO, WHO Collaborating Centres, the OECD, ECDC and the European Commission in diverse topics, including projects on access to medicines, preparedness, analysis of regulatory agencies, health information systems, cancer policies, infectious diseases, and public health foresight. She has experience with qualitative research methods in policy research, monitoring of indicators, and public health foresight methods. She has developed and delivered public health foresight training and supported experts in building foresight capacity. Her research interests include One Health and health in all policies, health inequalities and inequities, access to healthcare, access to health commodities and health technologies, infectious diseases and AMR, determinants of health and NCDs, mental health, and public health foresight.

Moye Holz received her Ph.D. in global health and health policies from the University of Groningen.

Education

Ph.D. in global health and health policies, University of Groningen; M.Sc. in international health, University of Heidelberg; B.Sc. in biology and pharmaceutical chemistry, UNAM

Languages

Spanish; English

Selected Work

  • Fifi Olumogba, Callum Gunn, Manon Richard-Sheridan, Daniela Moye Holz, Consensus building research to identify the 'ideal' policy framework for early cancer care, RAND Europe (RRA-4835-1), 2026
  • Sarah Parkinson1 , Saoirse Moriarty1 , Fifi Olumogba1 , Katarina Pisani1 , Daniela Moye Holz1 , Daniela Rodriguez Rincon1 , Cyril Barbezange2 , Eeva K Broberg2, "Improving public health laboratory preparedness at European Union level: learning points from experiences during the COVID-19 pandemic," Eurosurveillance, 31(32), 2026
  • Elizabeth N Mutubuki, Daniela Moye-Holz, Mariana Peyroteo, Luís Velez Lapão, Henk B M Hilderink,, "Foresight in public health: a tutorial on application and insights on challenges from the PHIRI foresight exercise," European Journal of Public Health,, 34(Supplement), 2024
  • Moye Holz, D.M., I. van der Heide, M. Geise, M Rijken, J. Hansen., Cancer prevention, early detection, and screening: EU citizens’ perceptions and experiences. Report on focus groups with citizens in six EU Member States to support the implementation of the EU Mission on Cancer., European Commission, 2024
  • Heide, I. van der, Moye Holz, D., Rijken, M., Hansen, J., Access to financial products for persons with a history of cancer in EU Member States: an explorative study., European Commission, 2022
  • Moye Holz D, Vogler S., "Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America.," Appl Health Econ Health Policy, 20(1), 2022
  • Moye-Holz, D., Dreser, A., Gómez-Dantés, O., Wirtz, V.J. "Promoting Access to Cancer Medicines in Mexico: Seguro Popular Key Policy Components," in Babar, Z, Global Pharmaceutical Policy, Palgrave Macmillan, 2020
  • Moye-Holz D, Dreser A, van Dijk JP, Reijneveld SA, Hogerzeil H., "Access to cancer medication in public hospitals in a middle-income country: The view of stakeholders," Res Social Adm Pharm, 16(9), 2020

Authored by Daniela Moye Holz

  • Content Type
  • Topic
  • Region
  • Date
3 Results